US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Takeda Pharmaceutical Co Ltd

15.32

+0.29001.93%

Pre-market: 15.320.00000.00%05:13 EDT

Volume:1.39M

Turnover:21.25M

Market Cap:48.35B

PE:37.01

High:15.39

Open:15.30

Low:15.29

Close:15.03

Loading ...

Overview Company News Filings

Hutchmed to Receive $10 Million Milestone Payment Through Takeda

MT Newswires Live

Hutchmed to receive milestone payment from Takeda

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?

Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst

Keros Therapeutics, Takeda in Elritercept Licensing Pact

Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept

MT Newswires Live

Takeda, Keros Therapeutics enter exclusive elritercept license agreement

Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept

Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook

Why Takeda (TAK) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan

MT Newswires Live

Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

Why this major drugmaker no longer has an ‘IT department’

Top brokers name 3 ASX shares to buy next week

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Trump victory is a win for Japan equities, a loss for China – analyst

New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":15.32,"timestamp":1746216000000,"preClose":15.03,"halted":0,"volume":1387023,"hourTrading":{"tag":"盘前","latestPrice":15.32,"preClose":15.32,"latestTime":"05:13 EDT","volume":9,"amount":137.88,"timestamp":1746436432860},"delay":0,"floatShares":3021115373,"shares":3156322898,"eps":0.413946,"marketStatus":"Pre-Mkt","change":0.29,"latestTime":"05-05 07:00:34 EDT","open":15.3,"high":15.39,"low":15.285,"amount":21248436.432465,"amplitude":0.006986,"askPrice":16.1,"askSize":1830,"bidPrice":13.72,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.413946,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746451800000},"marketStatusCode":1,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":15.32,"dividendRate":0.020235,"preHourTrading":{"tag":"盘前","latestPrice":15.32,"preClose":15.32,"latestTime":"05:13 EDT","volume":9,"amount":137.88,"timestamp":1746436432860},"postHourTrading":{"tag":"盘后","latestPrice":15.32,"preClose":15.32,"latestTime":"16:58 EDT","volume":3634,"amount":55673.61,"timestamp":1746219520966},"volumeRatio":0.8339106079386022,"impliedVol":0.2693,"impliedVolPercentile":0.3695},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3021115373,"roa":"2.51%","roe":"2.94%","lyrEps":0.304413,"volumeRatio":0.8339106079386022,"shares":3156322898,"dividePrice":0.31,"high":15.39,"amplitude":0.006986,"preClose":15.03,"low":15.285,"week52Low":12.575,"pbRate":"0.94","psRate":"1.52","week52High":15.39,"institutionHeld":0.1164,"latestPrice":15.32,"committee":-0.896373,"eps":0.413946,"divideRate":0.020235,"volume":1387023,"delay":0,"ttmEps":0.413946,"open":15.3,"prevYearClose":13.24,"prevWeekClose":15.32,"prevMonthClose":15.29,"prevQuarterClose":14.87,"fiveDayClose":15.03,"twentyDayClose":15.19,"sixtyDayClose":13.37,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491422163","title":"Hutchmed to Receive $10 Million Milestone Payment Through Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2491422163","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491422163?lang=en_us&edition=fundamental","pubTime":"2024-12-13 17:59","pubTimestamp":1734083995,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) said late Thursday it will receive a $10 million milestone payment through its partner Takeda (TAK) following a national reimbursement recommendation in Spain for Fruzaqla as a treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK1587","BK4531","BK1191","BK4585","HCM","BK1588","00013","BK4007","TAK"],"gpt_icon":0},{"id":"2491361011","title":"Hutchmed to receive milestone payment from Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2491361011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491361011?lang=en_us&edition=fundamental","pubTime":"2024-12-13 08:11","pubTimestamp":1734048715,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) announced hat it will receive a $10M milestone payment by its partner Takeda (TAK). Takeda received a national reimbursement recomme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hutchmed-to-receive-milestone-payment-from-takeda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hutchmed-to-receive-milestone-payment-from-takeda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","TAK","HCM","BK4531"],"gpt_icon":0},{"id":"2491366254","title":"Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=2491366254","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491366254?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:30","pubTimestamp":1734042600,"startTime":"0","endTime":"0","summary":"Six Late-Stage Programs with Peak Revenue Potential of $10B - $20B1 Poised to Deliver Sustainable Growth. Expected Phase 3 Data Readouts in 2025 for Oveporexton , Zasocitinib  and Rusfertide . Regulatory Filings for Oveporexton , Zasocitinib  and Rusfertide  on Track for Fiscal Years 2025 - 2026. Five Additional Filings Anticipated in Fiscal Years 2027 - 2029 Including First Indication Submissions for Mezagitamab , Fazirsiran  and Elritercept . \"We are focused on advancing our innovative pipeline and accelerating late-stage programs to deliver sustainable revenue growth to 2030 and beyond, building upon the strong momentum of our Growth and Launch Products,\" said Christophe Weber, Takeda chief executive officer. \"The first three Phase 3 programs will read out in 2025, initiating a cadence of potential filings across multiple indications over the next several years.\". zasocitinib, an investigational next-generation, highly selective and potent oral allosteric tyrosine kinase 2  inhibito","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ntk1Yv.Bmzenaulsixh_Rw--~B/aD0yNjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/93f9c4ed7328b2bb51fcd99754043cf1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ntk1Yv.Bmzenaulsixh_Rw--~B/aD0yNjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/93f9c4ed7328b2bb51fcd99754043cf1"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-spotlights-high-value-stage-223000502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TAK","SSI"],"gpt_icon":0},{"id":"2490023572","title":"ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490023572","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490023572?lang=en_us&edition=fundamental","pubTime":"2024-12-11 02:13","pubTimestamp":1733854380,"startTime":"0","endTime":"0","summary":"ADMA Biologics ADMA is witnessing a phenomenal run this year. Its shares have skyrocketed 320.6% year to date against the industry’s decline of 7.4%. The stock has also outperformed the sector and the S&P 500 during the aforementioned period.ADMA has recently hit a new 52-week high of $23.64 on Nov. 11. The stock fell 19% since then and is currently trading at $19.01.The stupendous rally can be attributed to the company’s consistently strong quarterly performance and increased guidance.ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.The company’s top line currently comprises sales of three FDA-approved products — Bivigam , Asceniv  and Nabi-HB .ADMA expects to file its supplemental biologics license application  over the coming quarters, with a potential approval for label expansion in the first half of 2026. A potential label expansion will strengthen ADMA’s product portfolio.While reporting thi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/r3LkX1bo0SJtXvRIU47BTQ--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3615a98c17145f2f704cb1a2bf1cf669","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/r3LkX1bo0SJtXvRIU47BTQ--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3615a98c17145f2f704cb1a2bf1cf669"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adma-stock-falls-19-52-181300731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TAK","BK4007","ADMA","GRFS","BK4139"],"gpt_icon":0},{"id":"2488926283","title":"Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2488926283","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488926283?lang=en_us&edition=fundamental","pubTime":"2024-12-04 01:37","pubTimestamp":1733247444,"startTime":"0","endTime":"0","summary":"Elritercept is a late-stage investigational activin inhibitor designed to treat anemia associated with certain hematologic cancers, including myelodysplastic syndromes and myelofibrosis.Also Read: Analyst Sees Keros Therapeutics As Next Acceleron, the Set For Major Biotech Growth. The FDA has granted Fast Track designation for elritercept for very low-, low- and intermediate-risk MDS.Myelodysplastic syndromes and myelofibrosis are characterized by inadequate blood cell production, often leading to severe anemia.In early clinical studies, elritercept has shown promising clinical activity and a manageable safety profile in patients with very low-, low- and intermediate-risk myelodysplastic syndromes as a monotherapy and in patients with myelofibrosisin combination with standard of care.The Phase 3 RENEW trial evaluating elritercept in adult patients with transfusion-dependent anemia with very low-, low- or intermediate-risk myelodysplastic syndromeswill begin enrollment soon.Takeda will ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1nLH8gIx4cuqE1hjHF8nLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/5f5c05fa8aa1858c6c863baf52205a2d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1nLH8gIx4cuqE1hjHF8nLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/5f5c05fa8aa1858c6c863baf52205a2d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keros-therapeutics-licensing-deal-takeda-173724356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0971096721.USD","LU2089283258.USD","IE00BKVL7J92.USD","BK4581","LU1548497426.USD","LU2271345857.HKD","BK4007","LU0106261372.USD","BK4127","LU0158827948.USD","LU0006306889.USD","LENZ","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU1989772840.SGD","LU2111349929.HKD","LU1720051108.HKD","LU1363072403.SGD","BK4534","LU0314104364.USD","LU2357305700.SGD","LU0158827781.USD","BK4588","LU1989772923.USD","LU1668664300.SGD","BK4504","LU2089284900.SGD","BK4585","LU0106831901.USD","KROS","LU2023251221.USD","LU2028103732.USD","BK4139","BK4516","LU0225283273.USD","LU0267386448.USD","LU1162221912.USD","LU0320765646.SGD","TAK","LU0098860793.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2488760917","title":"Keros Therapeutics, Takeda in Elritercept Licensing Pact","url":"https://stock-news.laohu8.com/highlight/detail?id=2488760917","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488760917?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:34","pubTimestamp":1733232840,"startTime":"0","endTime":"0","summary":"Keros Therapeutics has inked an agreement potentially worth more than $1 billion with Japan's Takeda Pharmaceutical aimed at advancing Keros' elritercept drug candidate.Keros and Takeda on Tuesday said the deal gives Takeda an exclusive license to further develop, manufacture and commercialize elritercept outside of mainland China, Hong Kong and Macau in exchange for an upfront payment of $200 million.Elritercept is in late-stage development for the treatment of anemia associated with certain blood cancers, including myelodysplastic syndromes and myelofibrosis.Keros, a Lexington, Mass., clinical-stage biopharmaceutical company, said it is eligible to receive development, approval and commercial milestones with the potential to exceed $1.1 billion, along with royalties on product sales.Takeda said the addition of elritercept bolsters its oncology pipeline and introduces a potential future growth driver for the Osaka-based drugmaker.Elritercept is a potential rival to Bristol Myers Squib","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4139","LENZ","BK4007","KROS"],"gpt_icon":0},{"id":"2488740911","title":"Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept","url":"https://stock-news.laohu8.com/highlight/detail?id=2488740911","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488740911?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:52","pubTimestamp":1733230322,"startTime":"0","endTime":"0","summary":"Keros Therapeutics  said Tuesday it has agreed to provide Takeda Pharmaceutical  with a global commercial license for elritercept, as well as to collaborate on the drug candidate's development.Keros said it expects to receive an upfront payment of $200 million, with milestone payments that could reach up to $1.1 billion. It also expects to receive tiered royalties on net sales.The upfront payment would extend Keros' operational runway through Q4 of 2028, the company said.The agreement is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, Keros said.Elritercept is currently in late-stage clinical trials for myelodysplastic syndrome and myelofibrosis, according to Keros.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007","KROS","BK4139","LENZ"],"gpt_icon":0},{"id":"2488919876","title":"Takeda, Keros Therapeutics enter exclusive elritercept license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919876","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488919876?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:15","pubTimestamp":1733228158,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that it has entered into an exclusive licensing agreement with Keros Therapeutics (KROS) to further develop, manufacture and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-keros-therapeutics-enter-exclusive-elritercept-license-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-keros-therapeutics-enter-exclusive-elritercept-license-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4139","BK4007","KROS","LENZ"],"gpt_icon":0},{"id":"2488916961","title":"Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2488916961","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488916961?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227200,"startTime":"0","endTime":"0","summary":"Elritercept is a late-stage, potentially best-in-class activin inhibitor designed to treat anemia associated with certain hematologic cancers, including myelodysplastic syndromes and myelofibrosis. Takeda to receive exclusive global license in all territories outside of mainland China, Hong Kong and Macau. Transaction builds upon Takeda’s legacy in the treatment of hematologic cancers and advances company’s global oncology strategy. OSAKA, Japan & CAMBRIDGE, Mass., December 03, 2024----Takeda  today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc.  to further develop, manufacture and commercialize elritercept worldwide outside of mainland China, Hong Kong and Macau.\"We are excited to partner with Takeda, whose global reach and expertise in oncology and hematology will help unlock elritercept’s potential for patients with MDS and MF,\" said Jasbir S. Seehra, Ph.D., Chair and Chief Executive Officer at Keros Therapeutics. \"With a differenti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Mtrw27NZWWLQ31pFftNF8Q--~B/aD0yNjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ab83e63c40e11825b14fac38a19f4ad0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Mtrw27NZWWLQ31pFftNF8Q--~B/aD0yNjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ab83e63c40e11825b14fac38a19f4ad0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-strengthens-oncology-pipeline-elritercept-120000571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","MF","BK4526","LENZ","BK4539","BK4113","BK4007","BK4139","TAK"],"gpt_icon":0},{"id":"2488091639","title":"Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept","url":"https://stock-news.laohu8.com/highlight/detail?id=2488091639","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488091639?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:00","pubTimestamp":1733227200,"startTime":"0","endTime":"0","summary":"Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and tiered ro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990449/0/en/Keros-Therapeutics-Announces-Global-License-Agreement-with-Takeda-to-Advance-Elritercept.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2488801915","title":"Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2488801915","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488801915?lang=en_us&edition=fundamental","pubTime":"2024-12-03 19:30","pubTimestamp":1733225447,"startTime":"0","endTime":"0","summary":"Unlock your investing potential with TipRanks Premium - Now At 40% OFF!Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. Takeda Pharmaceutical Company has raised its full-year management guidance for FY2024 following a robust first-half performance, driven by the successful launch of several new products and a return to double-digit growth for its established drug ENTYVIO. The company’s Growth & Launch Products segment saw an 18.7% increase at constant exchange rates, comprising nearly half of Takeda’s total revenue. With a focus on expanding its innovative pipeline, Takeda is poised for sustainable growth as it continues to invest in late-stage programs targeting high medical need areas.For further insights into TAK stock, check out TipRanks’ Stock Analysis page.OSCV, RBNK: 2 ETFs with Upside Potential and Steady Dividends. Upcoming Stock Splits This Week  – Stay Invested. SpaceX Rival Rocket Lab USA’s Stock Soars to New Highs","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BemfyP1UBzXHKKZLDQ1ooQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c37c6416e3d93ec36371ae85ba3ad4a9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BemfyP1UBzXHKKZLDQ1ooQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c37c6416e3d93ec36371ae85ba3ad4a9"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/takeda-strong-fy2024-h1-boosts-113047032.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-strong-fy2024-h1-boosts-113047032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2488744685","title":"Why Takeda (TAK) Is One of the Most Profitable Pharmaceutical Stocks Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2488744685","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488744685?lang=en_us&edition=fundamental","pubTime":"2024-12-01 05:29","pubTimestamp":1733002192,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited  stands against the other most profitable pharmaceutical stocks.The Pharmaceutical Industry: Growth, Innovation, and Emerging Challenges. Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the term \"defensive\" a step further than practically any other industry. Improvements in medical technology, medications, and therapeutic approaches have changed the course of patient care. As the need for quick results has grown, pharmaceutical corporations in particular have drawn much attention. Global pharmaceutical manufacturing was estimated to be worth $516.48 billion in 2022, according to a Grand View Research analysis. From 2023 to 2030, the industry is expected to expand at a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Jiiu1inYNngv8pvX5zXuCg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3ad0fcbe3a3becbcf2045309a3fdde75","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Jiiu1inYNngv8pvX5zXuCg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3ad0fcbe3a3becbcf2045309a3fdde75"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-takeda-tak-one-most-212952496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4159","BK4007","CAGR","TAK"],"gpt_icon":0},{"id":"2485123675","title":"Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2485123675","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485123675?lang=en_us&edition=fundamental","pubTime":"2024-11-22 17:01","pubTimestamp":1732266067,"startTime":"0","endTime":"0","summary":"Hutchmed  said late Thursday it will receive a milestone payment after partner Takeda  launched Fruzaqla capsules in Japan as a therapy for metastatic colorectal cancer.The launch follows approval for the manufacturing and sale of Fruzaqla by Japan's Ministry of Health, Labour and Welfare.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4007","TAK","BK1191","00013","BK1588","BK4585","HCM","BK1587","BK4531"],"gpt_icon":0},{"id":"2485114204","title":"Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2485114204","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485114204?lang=en_us&edition=fundamental","pubTime":"2024-11-21 00:55","pubTimestamp":1732121714,"startTime":"0","endTime":"0","summary":"onimate/iStock via Getty Images Takeda Pharmaceutical  has inked a collaboration agreement with privately held Alloy Therapeutics to develop the former's proprietary induced pluripotent stem cell  derived CAR-T cell platform  and iPSC-derived CAR-NK platform .  The companies noted that the paternship will help Alloy develop therapies to treat solid and hematological malignancies.  A news release noted that iCAR-T \"has potential to develop 'off-the-shelf' cell therapies, offering the potential for best-in-class performance with enhanced potency, and significantly lower manufacturing costs compared to autologous cell therapy.\"   Terms call for Alloy to receive co-exclusive rights to commercialize iCAR-T and iCAR-NK products for oncology indications. Also, the company wll use its exisiting expertise to advance the iCAR-T/NK platforms and provide broader access to the technology for future partners.","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1542564381/image_1542564381.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1542564381/image_1542564381.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4312597-takeda-deal-alloy-therapeutics-develop-cell-therapy-platforms-cancer","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["TAK","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2484622229","title":"Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484622229?lang=en_us&edition=fundamental","pubTime":"2024-11-19 14:50","pubTimestamp":1731999040,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Therap (LCTX – Research Report), Veeva Syste...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lineage-therap-lctx-veeva-systems-veev-and-takeda-pharmaceutical-company-tak?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lineage-therap-lctx-veeva-systems-veev-and-takeda-pharmaceutical-company-tak?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","BK4504","LCTX","BK4585","BK4534","BK4137","BK4007","LU0058720904.USD","BK4588","BK4528","TAK","VEEV","LU1989764664.SGD","BK4139","LU1989764748.USD","HCSG","BK4167","LU0266013472.USD"],"gpt_icon":0},{"id":"2483565948","title":"Why this major drugmaker no longer has an ‘IT department’","url":"https://stock-news.laohu8.com/highlight/detail?id=2483565948","media":"Fortune","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483565948?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:46","pubTimestamp":1731516364,"startTime":"0","endTime":"0","summary":"When Gabriele Ricci became chief data and technology officer at Takeda Pharmaceutical, one of the biggest cultural changes he made was eliminating the term “information technology.”“We don’t use the word IT anymore,” says Ricci, who was appointed to lead the data, digital, and technology function at the Japan-based pharmaceutical giant since 2022. “We truly believe our function is a business function.”Three years ago, 80% of the company’s technology needs were performed by external contractors. Ricci disliked relying so heavily on third parties, and Takeda hired thousands of engineers, data scientists, and architects. He put them in three major innovation centers, called “digital factories” internally, in India, Mexico, and Slovakia to co-develop technology with various business functions.Takeda is both buying and building generative AI tools, using models from providers including Microsoft, OpenAI, Anthropic, and Amazon Web Services. In areas where Takeda wants to retain a more clear ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/aA_OfS6x_7DpM86bYspl.w--~B/aD0xMDAwO3c9MTUwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/416640ec97e8bae8fa4501a40f66cd22","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/aA_OfS6x_7DpM86bYspl.w--~B/aD0xMDAwO3c9MTUwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/416640ec97e8bae8fa4501a40f66cd22"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-major-drugmaker-no-longer-164604620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","IE0004086264.USD","BK4588","BK4528","BK4587","GB00B4LPDJ14.GBP","BK4527","IE0009356076.USD","IE00B4YYXB79.USD","BK4567","IE00B775SV38.USD","IE00BBT3K403.USD","IE00B3S45H60.SGD","IE00BDCRKT87.USD","BK4534","MSFT","BK4503","IE0004445015.USD","IE0004445239.USD","IE00B19Z8W00.USD","IE000ITXATA3.USD","GB00BDT5M118.USD","IE00B1XK9C88.USD","IE00BFXG0V08.USD","IE00BHPRN162.USD","IE00BKPKM429.USD","IE0034235295.USD","TAK","BK4533","IE00BFSS7M15.SGD","BK4577","BK4548","IE00BK4W5M84.HKD","BK4097","IE0009G5SDU7.USD","IE000KEQY171.SGD","IE00BJTD4N35.SGD","BK4532","IE00BJLML261.HKD","BK4550","IE00BLSP4239.USD","IE0005OL40V9.USD","IE00B19Z8X17.USD","BK4581","IE0034235303.USD","IE00B7KXQ091.USD","BK4554","BK4576","IE0004091025.USD","IE00BJTD4V19.USD"],"gpt_icon":1},{"id":"2482080394","title":"Top brokers name 3 ASX shares to buy next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2482080394","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482080394?lang=en_us&edition=fundamental","pubTime":"2024-11-10 05:08","pubTimestamp":1731186480,"startTime":"0","endTime":"0","summary":"It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Her","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/10/top-brokers-name-3-asx-shares-to-buy-next-week-242/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","BK7504","BK7507","CSL.AU","MIN.AU","BK7508","BK7511","TAK","BK7067","XRO.AU","BK7501","BK4007","BK7016","BK7503"],"gpt_icon":0},{"id":"2481903900","title":"Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903900","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903900?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"Third quarter performance driven by strong portfolio royalty revenue growth. 2024 full year revenue guidance increased to $160 million - $165 million  and core adjusted earnings per diluted share1 increased to $5.50 - $5.70 . Company to hold Investor and Analyst Day in Boston on December 10, 2024. Conference call begins at 8:30 a.m. Eastern Time today. JUPITER, Fla., November 07, 2024----Ligand Pharmaceuticals Incorporated  today reported financial results for the three and nine months ended September 30, 2024, and provided an operating forecast and business update. Ligand management will host a conference call and webcast today at 8:30 a.m. Eastern Time to discuss this announcement and answer questions.Cost of Captisol was $2.4 million for the third quarter of 2024, compared with $3.5 million for the same period in 2023, with the change due to timing of customer orders of Captisol sales. Amortization of intangibles was $8.3 million for the third quarter of 2024, compared with $8.2 mil","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G.sCoqQcMaJyGLjD5so5sA--~B/aD00Mjc7dz0xMjIyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9b0006d2cf8eb93e50e92f79add01df5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G.sCoqQcMaJyGLjD5so5sA--~B/aD00Mjc7dz0xMjIyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9b0006d2cf8eb93e50e92f79add01df5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ligand-reports-third-quarter-2024-120000439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B1BXHZ80.USD","TAK","IE0009355771.USD","BK4585","IE00B2B36J28.USD","LU1917777945.USD","BK4559","BK4011","IE00BSNM7G36.USD","SG9999001077.SGD","LU0985320562.USD","LU1934455863.HKD","BK4139","LU0234572021.USD","LU0058720904.USD","LU1116320737.USD","IE00BN8TJ469.HKD","BK4548","LU2237438978.USD","LU0965509101.SGD","LU1061106388.HKD","LU1559883803.SGD","LU0070302665.USD","LU0053666078.USD","IE00B4R5TH58.HKD","LU1037948897.HKD","MLM","LU1430594728.SGD","LU1941712264.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","MRK","IE00BJT1NW94.SGD","LU1934455277.USD","LU1066051498.USD","LU0289739699.SGD","LU0861579265.USD","LU0266013472.USD","LU1934455194.USD","LU1057294990.SGD","LU0265550946.USD","LU1023059063.AUD","LGND","LU0265550359.USD","LU0122379950.USD","LU0320765489.SGD","LU0208291251.USD","LU0006306889.USD","LU0106261372.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2481576987","title":"Trump victory is a win for Japan equities, a loss for China – analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2481576987","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481576987?lang=en_us&edition=fundamental","pubTime":"2024-11-06 23:49","pubTimestamp":1730908152,"startTime":"0","endTime":"0","summary":"Richard Drury/DigitalVision via Getty Images The Republican presidential election win is moving financial markets to discount significant gains in the U.S. dollar and rises in the longer dated U.S. do","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303660047/image_1303660047.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303660047/image_1303660047.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4255566-trump-victory-is-a-win-for-japan-equities-a-loss-for-china-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["FXI","BK4170","EWA","LU0971096721.USD","STBFY","TAK","LU0314104364.USD","LU0267386448.USD","IE00BKVL7J92.USD","LU1668664300.SGD","BK4534","LU1162221912.USD","LU1074936037.SGD","FLAU","BK4585","OMRNY","PIN","IE00BZ1G4Q59.USD","PIN.AU","APELY","LU0006306889.USD","LU0106261372.USD","BK4504","BK4007","BK4127","LU1548497426.USD","BK4523","LU1720051017.SGD","LU1720051108.HKD","TTDKY","BK4516","LU0106831901.USD","FLIN","BK4588","EWJ","LU1363072403.SGD","LU2357305700.SGD","BK4582","EEM","ALPMY","BK4148","LU0098860793.USD","MCHI","FUJIY","INDA","LU1989772923.USD","GXC","BK4177","BK4581","LU0225283273.USD"],"gpt_icon":1},{"id":"2480762300","title":"New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD","url":"https://stock-news.laohu8.com/highlight/detail?id=2480762300","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480762300?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:01","pubTimestamp":1730725260,"startTime":"0","endTime":"0","summary":"Approximately 300,000 Canadians are living with IBD, with the number projected to grow to 470,000 by 2035.1. TORONTO, Nov. 4, 2024 /CNW/ -Takeda Canada Inc.  announces new data highlighting the impact Inflammatory Bowel Disease  has on Canadians. The data reveals insights into how the disease affects daily life, the challenges to timely access to care and treatment, and the unmet need to prioritize mental health support for those living with IBD.The Takeda 300,000 Reasons Why Survey [\"the survey\"], conducted by Leger, a leading North American market research firm on August 21 – 28, 2024, surveyed 251 Canadians, which included 130 people living with IBD and 121 caregivers for people with IBD.2. The survey is part of Takeda's 300,000 Reasons Why campaign, which seeks to highlight the urgent need to address the challenges faced by Canadian IBD patients and elevate the standard of care. Its findings emphasize the often-overlooked mental health impacts of the disease, revealing how they aff","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Kr7nAfxvdqS4TLabrvWQ0A--~B/aD0yMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/3161d901c85c5a5efad4f97f7e79610a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Kr7nAfxvdqS4TLabrvWQ0A--~B/aD0yMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/3161d901c85c5a5efad4f97f7e79610a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/survey-data-highlights-importance-prioritizing-130100410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IBD","BK4116","CD","BK4007","TAK"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1746691200000,"name":null,"time":"Pre-Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44},{"market":"US","date":"2024-07-31","symbol":"TAK","fiscalQuarterEnding":"2024/06","expectedEps":0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2024-05-09","symbol":"TAK","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2025-05-02","current":32.102637,"percent":0.59854,"low":9.919003,"twenty":15.728527,"median":29.784868,"eighty":45.020529,"high":448.636969,"avg":39.189931,"sd":42.600526,"marketCap":45944348076.13},"quantilePoints":[{"date":"2020-05-08","current":438.427339,"twenty":25.784378,"median":36.398869,"eighty":81.931076,"marketCap":54638780722.19},{"date":"2020-05-15","current":141.266146,"twenty":25.78995,"median":36.47458,"eighty":82.305276,"marketCap":58229887273.26},{"date":"2020-05-22","current":142.498528,"twenty":25.895823,"median":36.514941,"eighty":82.473666,"marketCap":58640622164.25},{"date":"2020-05-29","current":147.568898,"twenty":26.094305,"median":36.5454,"eighty":82.720638,"marketCap":60618343666.07},{"date":"2020-06-05","current":142.287262,"twenty":26.802799,"median":36.578836,"eighty":82.960126,"marketCap":57369545717.84},{"date":"2020-06-12","current":140.456295,"twenty":26.987384,"median":36.601121,"eighty":83.356777,"marketCap":57891751795.22},{"date":"2020-06-19","current":141.688677,"twenty":27.833349,"median":36.617455,"eighty":83.603749,"marketCap":58614309903.35},{"date":"2020-06-26","current":139.787288,"twenty":28.382494,"median":36.66065,"eighty":84.02269,"marketCap":57689640075.75},{"date":"2020-07-02","current":134.083122,"twenty":28.490627,"median":36.703774,"eighty":84.187418,"marketCap":55151885879.75},{"date":"2020-07-10","current":129.224017,"twenty":28.584436,"median":36.784141,"eighty":85.31532,"marketCap":53543496364.44},{"date":"2020-07-17","current":130.667664,"twenty":28.683495,"median":36.800541,"eighty":86.385434,"marketCap":53972328180.49},{"date":"2020-07-24","current":133.164486,"twenty":28.804715,"median":36.81694,"eighty":87.725687,"marketCap":55658397179.21},{"date":"2020-07-31","current":49.030087,"twenty":28.880318,"median":36.830882,"eighty":88.33002,"marketCap":55557224542.23},{"date":"2020-08-07","current":49.695831,"twenty":29.000288,"median":36.883572,"eighty":88.247168,"marketCap":56220621340.2},{"date":"2020-08-14","current":51.954139,"twenty":29.120238,"median":36.973174,"eighty":88.149695,"marketCap":58424376584.77},{"date":"2020-08-21","current":52.698206,"twenty":29.210125,"median":37.019329,"eighty":87.725687,"marketCap":59589605364.98},{"date":"2020-08-28","current":51.875816,"twenty":29.296114,"median":37.194931,"eighty":87.39428,"marketCap":59006258563.45},{"date":"2020-09-04","current":50.217983,"twenty":29.358735,"median":37.349685,"eighty":86.853304,"marketCap":56544754820.4},{"date":"2020-09-11","current":51.079534,"twenty":29.413482,"median":37.496711,"eighty":86.502401,"marketCap":57600970548.14},{"date":"2020-09-18","current":52.071623,"twenty":29.482546,"median":37.644832,"eighty":86.409802,"marketCap":59718536367.45},{"date":"2020-09-25","current":51.23618,"twenty":29.528429,"median":37.70687,"eighty":86.307455,"marketCap":58079537631.11},{"date":"2020-10-02","current":47.267823,"twenty":29.55872,"median":37.818162,"eighty":86.127131,"marketCap":53733241411.92},{"date":"2020-10-09","current":48.45572,"twenty":29.570204,"median":38.056274,"eighty":85.695464,"marketCap":54928745380.19},{"date":"2020-10-16","current":45.740528,"twenty":29.581756,"median":38.101028,"eighty":85.328548,"marketCap":51955606617.4},{"date":"2020-10-23","current":45.688313,"twenty":29.610527,"median":38.151519,"eighty":85.068348,"marketCap":52213782354.12},{"date":"2020-10-30","current":90.341121,"twenty":29.668895,"median":38.172466,"eighty":85.328548,"marketCap":48419952386.27},{"date":"2020-11-06","current":96.588856,"twenty":29.692357,"median":38.217233,"eighty":86.409802,"marketCap":52398853598.67},{"date":"2020-11-13","current":100.410015,"twenty":29.692593,"median":38.315348,"eighty":87.847529,"marketCap":53780559103.29},{"date":"2020-11-20","current":101.776706,"twenty":29.697927,"median":38.413443,"eighty":88.520092,"marketCap":54951029488.93},{"date":"2020-11-27","current":104.091715,"twenty":29.726253,"median":38.431569,"eighty":89.212151,"marketCap":56090722051.49},{"date":"2020-12-04","current":108.749624,"twenty":29.809673,"median":41.476727,"eighty":89.840851,"marketCap":58500568009.94},{"date":"2020-12-11","current":107.940766,"twenty":29.825396,"median":42.195512,"eighty":90.113776,"marketCap":58227511975.44},{"date":"2020-12-18","current":108.136007,"twenty":29.898634,"median":42.406568,"eighty":90.568631,"marketCap":58641544051.05},{"date":"2020-12-24","current":104.063823,"twenty":29.940017,"median":42.671516,"eighty":90.966664,"marketCap":56275869966.77},{"date":"2020-12-31","current":104.733224,"twenty":29.971299,"median":42.851076,"eighty":91.332188,"marketCap":56879881356.69},{"date":"2021-01-08","current":103.059723,"twenty":29.97912,"median":42.920583,"eighty":91.791488,"marketCap":55589135003.46},{"date":"2021-01-15","current":100.437906,"twenty":29.989622,"median":43.181235,"eighty":92.111972,"marketCap":54236546808.57},{"date":"2021-01-22","current":100.047423,"twenty":30.031602,"median":43.418717,"eighty":92.258181,"marketCap":54029329143.49},{"date":"2021-01-29","current":103.143398,"twenty":30.073173,"median":43.598578,"eighty":92.394644,"marketCap":55216620705.7},{"date":"2021-02-05","current":31.781037,"twenty":30.157692,"median":43.665039,"eighty":92.535979,"marketCap":54432227223.55},{"date":"2021-02-12","current":31.919516,"twenty":30.223066,"median":43.441886,"eighty":92.526232,"marketCap":54935581599.54},{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41787899615.91},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42554175847.16},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41415614115.37},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39824219396.61},{"date":"2024-06-28","current":45.436656,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":40737102327.33},{"date":"2024-07-05","current":46.209907,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":41309547172.12},{"date":"2024-07-12","current":47.281654,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":42963991363.06},{"date":"2024-07-15","current":47.281654,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":43152064633.5},{"date":"2024-08-02","current":44.272889,"twenty":15.741453,"median":31.201154,"eighty":86.195362,"marketCap":44210960292.65},{"date":"2024-08-09","current":43.014896,"twenty":15.741453,"median":31.201154,"eighty":84.363274,"marketCap":43794562967.78},{"date":"2024-08-16","current":45.710595,"twenty":15.741453,"median":31.201154,"eighty":83.962818,"marketCap":46020941359.68},{"date":"2024-08-23","current":46.418876,"twenty":15.741453,"median":31.201154,"eighty":83.592523,"marketCap":47626372624.72},{"date":"2024-08-30","current":45.805737,"twenty":15.741453,"median":31.201154,"eighty":83.199613,"marketCap":47269997055.1},{"date":"2024-09-06","current":45.150312,"twenty":15.741453,"median":31.201154,"eighty":82.795478,"marketCap":47112822724.29},{"date":"2024-09-13","current":43.733749,"twenty":15.741453,"median":31.201154,"eighty":82.469924,"marketCap":46054603558.91},{"date":"2024-09-20","current":45.192598,"twenty":15.741453,"median":31.201154,"eighty":82.039594,"marketCap":47462516587.04},{"date":"2024-09-27","current":44.008604,"twenty":15.741453,"median":31.201154,"eighty":81.796364,"marketCap":45577615083.94},{"date":"2024-10-04","current":44.8226,"twenty":15.741453,"median":31.201154,"eighty":81.650426,"marketCap":45789892958.1},{"date":"2024-10-11","current":45.034027,"twenty":15.741453,"median":31.201154,"eighty":81.051706,"marketCap":45471085814.96},{"date":"2024-10-18","current":45.203169,"twenty":15.741453,"median":31.201154,"eighty":80.673764,"marketCap":45181771588.11},{"date":"2024-10-25","current":43.395465,"twenty":15.741453,"median":31.201154,"eighty":79.929106,"marketCap":42824171488.68},{"date":"2024-10-31","current":45.076313,"twenty":15.741453,"median":31.201154,"eighty":79.086292,"marketCap":44338714216.59},{"date":"2024-11-08","current":23.061963,"twenty":15.732274,"median":30.643838,"eighty":78.376176,"marketCap":43661674072.7},{"date":"2024-11-15","current":23.302476,"twenty":15.732274,"median":30.454139,"eighty":52.554614,"marketCap":43374550679.55},{"date":"2024-11-22","current":22.482544,"twenty":15.732274,"median":30.401826,"eighty":52.071623,"marketCap":42186009596.39},{"date":"2024-11-29","current":22.318557,"twenty":15.732274,"median":30.334902,"eighty":51.88887,"marketCap":42718018145.77},{"date":"2024-12-06","current":22.537206,"twenty":15.732274,"median":30.202359,"eighty":51.680009,"marketCap":43528672494.7},{"date":"2024-12-13","current":22.602801,"twenty":15.732274,"median":30.13984,"eighty":51.23618,"marketCap":43060561658.31},{"date":"2024-12-20","current":22.438814,"twenty":15.732274,"median":30.092447,"eighty":51.014265,"marketCap":41267393050.42},{"date":"2024-12-27","current":22.89251,"twenty":15.732274,"median":30.057852,"eighty":50.68792,"marketCap":42014127583.17},{"date":"2025-01-03","current":22.854246,"twenty":15.732274,"median":30.013965,"eighty":50.217983,"marketCap":42075712866},{"date":"2025-01-10","current":22.526274,"twenty":15.7304,"median":29.981195,"eighty":49.163236,"marketCap":41357424220.33},{"date":"2025-01-17","current":22.072578,"twenty":15.7304,"median":29.8898,"eighty":48.45572,"marketCap":41218860202.53},{"date":"2025-01-24","current":22.056179,"twenty":15.7304,"median":29.842804,"eighty":47.722096,"marketCap":41006037214.49},{"date":"2025-01-31","current":32.066996,"twenty":15.7304,"median":29.792729,"eighty":47.270589,"marketCap":43228239899.45},{"date":"2025-02-07","current":31.518451,"twenty":15.7304,"median":29.792729,"eighty":46.516772,"marketCap":43185471262.61},{"date":"2025-02-14","current":31.625402,"twenty":15.7304,"median":29.792729,"eighty":46.191026,"marketCap":43025162552.6},{"date":"2025-02-21","current":32.135858,"twenty":15.7304,"median":29.792729,"eighty":46.13785,"marketCap":44672438730.76},{"date":"2025-02-28","current":33.019632,"twenty":15.7304,"median":29.792729,"eighty":45.930637,"marketCap":45808555597.44},{"date":"2025-03-07","current":33.965435,"twenty":15.728527,"median":29.788798,"eighty":45.798539,"marketCap":47684395829.03},{"date":"2025-03-14","current":33.616527,"twenty":15.728527,"median":29.788798,"eighty":45.697226,"marketCap":47372923461.69},{"date":"2025-03-21","current":33.462021,"twenty":15.728527,"median":29.788798,"eighty":45.536889,"marketCap":46793573769.54},{"date":"2025-03-28","current":32.837181,"twenty":15.728527,"median":29.788798,"eighty":45.417077,"marketCap":45256999058.78},{"date":"2025-04-04","current":32.910692,"twenty":15.728527,"median":29.788798,"eighty":45.358128,"marketCap":46930689894.65},{"date":"2025-04-11","current":28.911716,"twenty":15.7304,"median":29.784868,"eighty":45.194712,"marketCap":41677459532.98},{"date":"2025-04-17","current":30.639215,"twenty":15.7304,"median":29.784868,"eighty":45.124941,"marketCap":44845997107.55},{"date":"2025-04-25","current":31.299454,"twenty":15.728527,"median":29.784868,"eighty":45.06475,"marketCap":45645722852.58},{"date":"2025-05-02","current":32.102637,"twenty":15.728527,"median":29.784868,"eighty":45.020529,"marketCap":45944348076.13}],"updateTime":1746425904355}}}